CRC Research Update — August 09, 2026
Today's colorectal cancer research highlights
crc-research
A collection of 422 issues
ctDNA-Guided Treatment Decisions Show Mixed Results in Stage II and III Colon Cancer
Skip to content
The CRC Digest
ctDNA-Guided Treatment Decisions Show Mixed Results in Stage II and III Colon Cancer
DYNAMIC-III found that escalation in ctDNA-positive stage III patients did not improve outcomes. (EClinicalMedicine)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care
Early Palliative Care Contact Linked to Reduced End-of-Life Healthcare Use
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Early Palliative Care Contact Linked to Reduced End-of-Life Healthcare Use
A nationwide Finnish study found that early specialist palliative care involvement (more than 30 days before death) was associated with lower healthcare utilization at end of life in patients with colorectal
Study Evaluates Trifluridine/Tipiracil in MSI-H/dMMR Metastatic CRC
Skip to content
The CRC Digest
▸ TREATMENT
Study Evaluates Trifluridine/Tipiracil in MSI-H/dMMR Metastatic CRC
A study across 10 Japanese hospitals aimed to evaluate trifluridine/tipiracil (with or without bevacizumab) in MSI-H/dMMR metastatic colorectal cancer, a population known to resist standard fluorouracil-based therapies. (Therapeutic Advances in Medical Oncology)
ctDNA Shows Promise for Risk Stratification but Mixed Results for Treatment Selection
Skip to content
The CRC Digest
◇ RESEARCH
ctDNA Shows Promise for Risk Stratification but Mixed Results for Treatment Selection
A review of circulating tumor DNA in GI cancers found that while postoperative ctDNA positivity identifies high-risk patients, recent trials show mixed results: DYNAMIC-III showed escalation in ctDNA-positive stage III disease
13-Year NordICC Data Show Colonoscopy Reduces CRC Incidence but Not Mortality
Skip to content
The CRC Digest
▪ SCREENING
13-Year NordICC Data Show Colonoscopy Reduces CRC Incidence but Not Mortality
Long-term follow-up from the NordICC trial comparing colonoscopy to no screening found a reduction in colorectal cancer incidence but no statistically significant mortality benefit at 13 years. (Gastroenterology)
This content is informational
CRC Research Update — August 08, 2026
Today's colorectal cancer research highlights
NCI-MATCH trial analysis compares tumor genomic alterations in adolescents and young adults versus older patients
Skip to content
The CRC Digest
NCI-MATCH trial analysis compares tumor genomic alterations in adolescents and young adults versus older patients
Analysis of 759 colorectal cancer patients from the NCI-MATCH trial compared genomic profiles between AYAs (18-39 years, n=43) and non-AYAs (40+ years) using a 143-gene panel. (JCO Precision
Review links colibactin-producing E. coli to early-onset colorectal cancer through distinct mutational signatures
Skip to content
The CRC Digest
◇ RESEARCH
Review links colibactin-producing E. coli to early-onset colorectal cancer through distinct mutational signatures
Genomic profiling has identified mutational signatures SBS88 and ID18 in colorectal tumors exposed to colibactin from pks+ E. coli, with emerging data suggesting enrichment in early-onset CRC. (Infection, Genetics and
Study identifies distinct stigma profiles among colorectal cancer patients with ostomies
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Study identifies distinct stigma profiles among colorectal cancer patients with ostomies
A cross-sectional survey of 449 patients with colorectal cancer and intestinal ostomy used latent profile analysis to identify stigma subtypes and found that stoma acceptance mediates the relationship between stigma